High Body Mass Index Disrupts the Homeostatic Relationship Between Pain Inhibitory Control and the Symptomatology in Patients with Knee Osteoarthritis—A Cross-Sectional Analysis from the DEFINE Study
Open Access
Abstract
Objective: As outlined in our previous study, this study aims to investigate the role of body mass index (BMI) as an effect modifier in the relationship between conditioned pain modulation (CPM) and clinical outcomes, including depression, quality of life, and pain in individuals with knee osteoarthritis (KOA). Methods: This cross-sectional analysis is part of the DEFINE Study in Rehabilitation. A total of 113 participants with KOA, admitted to the Instituto de Medicina Física e Reabilitação (IMREA) rehabilitation program, were included. Clinical and neurophysiological assessments were conducted, focusing on CPM, the Hamilton Depression Rating Scale (HDRS), and the SF-36 health survey. BMI was stratified into two categories based on the mean BMI of 31.99 kg/m2, and linear regression models were used to evaluate BMI as an effect modifier in the relationship between CPM and clinical outcomes. p-values below 0.10 for interaction terms (CPM × BMI) indicated effect modification. Results: In participants with BMI < 31.99 kg/m2, increased CPM was significantly associated with improved depression scores (lower HDRS) and enhanced physical functioning, emotional well-being, and reduced limitations due to emotional problems (SF-36). In contrast, no significant associations between CPM and these outcomes were found in participants with BMI ≥ 31.99 kg/m2. The results suggest that a higher BMI disrupts the salutogenic effects of endogenous pain control, diminishing the beneficial associations between CPM and both physical and psychological outcomes, as previously observed in fibromyalgia patients. Conclusions: BMI acts as an effect modifier in the relationship between CPM and clinical outcomes in individuals with KOA. Obesity appears to hinder the beneficial relationships between clinical symptoms and CPM, leading to a less favorable link between physical and emotional functioning and CPM. These findings highlight the importance of considering BMI in treatment strategies for KOA, particularly when addressing the impact of lifestyle and other modifiable factors that influence pain modulation.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/12943-8)
This publication has 22 references indexed in Scilit:
- High Body Mass Index Disrupts the Homeostatic Effects of Pain Inhibitory Control in the Symptomatology of Patients With FibromyalgiaThe Journal of Pain, 2024
- Hyperglycemia and Central Obesity Disrupt Conditioned Pain Modulation: A Single-Blind Crossover Randomized Controlled TrialThe Journal of Pain, 2024
- The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysisCancer Immunology, Immunotherapy, 2021
- Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studieseClinicalMedicine, 2020
- Obesity and Cancer Treatment Outcomes: Interpreting the Complex EvidenceClinical Oncology, 2020
- Defective Endogenous Pain Modulation in Fibromyalgia: A Meta-Analysis of Temporal Summation and Conditioned Pain Modulation ParadigmsThe Journal of Pain, 2018
- Effects of Motor Cortex Modulation and Descending Inhibitory Systems on Pain Thresholds in Healthy SubjectsThe Journal of Pain, 2012
- Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49yearsPsychiatry Research, 2011
- Recommendations on terminology and practice of psychophysical DNIC testingEuropean journal of pain, 2010
- Overweight, Obesity, and DepressionArchives of General Psychiatry, 2010